Structure Therapeutics Ownership
| GPCR Stock | 19.25 0.28 1.43% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Structure | Build AI portfolio with Structure Stock |
Structure Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.37. Some equities with similar Price to Book (P/B) outperform the market in the long run. Structure Therapeutics recorded a loss per share of 2.58. The entity had not issued any dividends in recent years. To learn more about Structure Therapeutics American call Raymond Stevens at 650 457 1978 or check out https://structuretx.com.Structure Therapeutics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Structure Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Structure Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Structure Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Structure Therapeutics' latest congressional trading
Congressional trading in companies like Structure Therapeutics, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Structure Therapeutics by those in governmental positions are based on the same information available to the general public.
| 2023-11-01 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Structure Therapeutics Outstanding Bonds
Structure Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Structure Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Structure bonds can be classified according to their maturity, which is the date when Structure Therapeutics American has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| STRYKER P 41 Corp BondUS863667AE17 | View | |
| STRYKER P 3375 Corp BondUS863667AH48 | View | |
| STRYKER P 4375 Corp BondUS863667AG64 | View | |
| STRYKER P 4625 Corp BondUS863667AJ04 | View | |
| STRYKER P 35 Corp BondUS863667AN16 | View | |
| STRYKER P 365 Corp BondUS863667AQ47 | View | |
| STRYKER PORATION Corp BondUS863667AY70 | View | |
| US863667AZ46 Corp BondUS863667AZ46 | View |
Pair Trading with Structure Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Structure Stock
| 0.76 | FNMFO | Federal National Mortgage | PairCorr |
| 0.72 | BAC-PL | Bank of America | PairCorr |
| 0.68 | AVAL | Grupo Aval | PairCorr |
| 0.65 | WF | Woori Financial Group Earnings Call This Week | PairCorr |
| 0.63 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.